價格：免費
更新日期：2018-08-11
檔案大小：2.8M
目前版本：1.0.0
版本需求：Android 4.1 以上版本
官方網站：http://www.ctbr.org
Email：stghaematology@gmail.com
聯絡地址：隱私權政策
About the South Australian Cancer Trials Network app
The South Australian Cancer Trials Network app is here for people affected by cancer, and their treating clinical teams to more easily identify a trial open in South Australia (SA). The app is populated by all sites in SA running cancer trials, covering both public and private settings. The app is supported by the SA Cancer Trials Network (SACTN) – a new initiative in SA to optimise the functioning and support for all cancer trials running across the state.
The SACTN will impact on clinical trials capacity in SA by building on current initiatives like the Adelaide Cancer Trials Education Collaborative, addressing already identified gaps, and establishing multiple stakeholder input and consensus on an appropriate path forward to delivering a best practice, forward-thinking, proactive network.
Alongside its core functions of supporting consumers, clinicians and trial sites, and generating and attracting new cancer trials for SA, the SACTN will enhance state-wide cancer treatment and care initiatives to better support optimal cancer care for all South Australians.
Please contact Greg Sharplin (University of South Australia) should you have any comments or questions regarding the SA Cancer Trials Network app.
Copyright:
This product incorporates software and/or data which is owned by South Eastern Sydney Local Health District (SESLHD) and Sydney Local Health District (SLHD) (in association with the Haematology Clinical Research Network, NSW Health) © 2013.
Condition of Download - Release and Indemnity:
Prior to downloading this ClinTrial Refer App (the App), the user agrees, in consideration for, and as a condition to, being able to download the App, that the user releases SESLHD and SLHD (the Licensors) in respect of all liability for loss, damage or injury which may be suffered by the user or any other person arising from or in connection with the App; and further the user agrees to indemnify the Licensors in respect of all liability for loss, damage or injury, which may be suffered by or against any person arising from or in connection with that user's use of the App.
